Temozolomide/PLGA microparticles: A new protocol for treatment of glioma in rats

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 901-906

  Zhang, Yu Hui ^a   Zhang, He ^b   Liu, Jian Min ^a   Yue, Zhi Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brain tumor; Chemotherapy; Glioma; Polymer

Indexed keywords

MICROSPHERE; POLYGLACTIN; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN NEOPLASMS; DACARBAZINE; GLIOMA; IN SITU NICK-END LABELING; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; RATS;

EID: 80052439840     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9531-2     Document Type: Article

References (27)

1. HA Fine KB Dear JS Loeffler PM Black GP Canellos 1993 Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 8 2585 2597 8453582 10.1002/1097-0142(19930415)71:8<2585: :AID-CNCR2820710825>3.0.CO;2-S 1:STN:280:DyaK3s3gtFCrtQ%3D%3D
2. FJ Attenello, et al. 2008 Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience Ann Surg Oncol 15 10 2887 2893 18636295 10.1245/s10434-008-0048-2
3. SE Combs, et al. 2008 Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens Int J Radiat Oncol Biol Phys 71 4 999 1005 18258384 10.1016/j.ijrobp.2007.11.064 1:CAS:528: DC%2BD1cXnsFGhtrw%3D
4. PY Wen S Kesari 2008 Malignant gliomas in adults N Engl J Med 359 5 492 507 18669428 10.1056/NEJMra0708126 1:CAS:528:DC%2BD1cXpt1Sgsrw%3D
5. AA Brandes 2003 State-of-the-art treatment of high-brain tumors Semin Oncol 30 6 Suppl 19 4 9 14765377 10.1053/j.seminoncol.2003.11.028
6. JY Wu, et al. 2008 Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status Ann Surg Oncol 15 11 3272 3277 18712569 10.1245/s10434-008-0078-9
7. I Zawlik, et al. 2009 Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study Neuroepidemiology 32 1 21 29 18997474 10.1159/000170088
8. FG Hutchison BJA Furr 1990 Biodegradable polymer systems for the sustained release of polypeptides J Control Release 13 2-3 279 294 10.1016/0168-3659(90)90018-O
9. H Okada H Toguchi 1995 Biodegradable microspheres in drug delivery Crit Rev Ther Drug Carrier Syst 12 1 1 99 8521523 1:CAS:528:DyaK2MXpsVCqs78%3D
10. M Higaki T Ishihara N Izumo M Takatsu Y Mizushima 2005 Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate Ann Rheum Dis 64 8 1132 1136 15695536 10.1136/ard.2004.030759 1:CAS:528:DC%2BD2MXpslGmsr0%3D
11. P Menei, et al. 1993 Biodegradation and brain tissue reaction to poly(D, L-lactide-co-glycolide) microspheres Biomaterials 14 6 470 478 8507795 10.1016/0142-9612(93)90151-Q 1:CAS:528:DyaK3sXls1Ols7g%3D
12. DF Emerich, et al. 1999 Biocompatibility of poly (DL-lactide-co- glycolide) microspheres implanted into the brain Cell Transpl 8 1 47 58 1:STN:280:DyaK1M3mvVGqtQ%3D%3D
13. KB Bjugstad, et al. 2008 Biocompatibility of PEG-based hydrogels in primate brain Cell Transpl 17 4 409 415 1:STN:280:DC%2BD1czlvVGlsw%3D%3D
14. Y Zhong RV Bellamkonda 2008 Biomaterials for the central nervous system J R Soc Interface 5 26 957 975 18477539 10.1098/rsif.2008.0071 1:CAS:528:DC%2BD1cXhtFajsLzE
15. SD Baker, et al. 1999 Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer Clin Cancer Res 5 2 309 317 10037179 1:CAS:528:DyaK1MXhsVWrt7s%3D
16. A Riccardi G Mazzarella G Cefalo, et al. 2003 Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients Cancer Chemother Pharmacol 52 6 459 464 13680160 10.1007/s00280-003-0677-x 1:CAS:528:DC%2BD3sXovVKntb0%3D
17. H Zhang S Gao 2007 Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro Int J Pharm 329 1-2 122 128 17000068 10.1016/j.ijpharm.2006.08.027 1:CAS:528:DC%2BD28XhtlCmtLvJ
18. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. San Diego; 1998.
19. CBTRUS. Statistical report: primary brain tumors in the United States 2000-2004. In: Edition Published by the Central Brain Tumor Registry of the United States 2008; 2008.
20. WK Yung, et al. 1999 Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal brain tumor group J Clin Oncol 17 9 2762 2771 10561351 1:CAS:528:DyaK1MXmtlWru7s%3D
21. WK Yung, et al. 2000 A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 5 588 593 10944597 10.1054/bjoc.2000.1316 1:CAS:528:DC%2BD3cXmvVCgsrs%3D
22. S Oshiro H Tsugu F Komatsu, et al. 2009 Efficacy of temozolomide treatment in patients with high-grade glioma Anticancer Res 29 3 911 917 19414327 1:CAS:528:DC%2BD1MXltlOqt74%3D
23. VA Trinh SP Patel WJ Hwu 2009 The safety of temozolomide in the treatment of malignancies Expert Opin Drug Saf 8 4 493 499 19435405 10.1517/ 14740330902918281 1:CAS:528:DC%2BD1MXns1CgsLw%3D
24. Y Onuki U Bhardwaj F Papadimitrakopoulos DJ Burgess 2008 A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response J Diabetes Sci Technol 2 6 1003 1015 19885290
25. S Brem, et al. 2007 Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model Cancer Chemother Pharmacol 60 5 643 650 17256133 10.1007/s00280-006-0407-2 1:CAS:528:DC%2BD2sXovFSrsbg%3D
26. ES Newlands MF Stevens SR Wedge RT Wheelhouse C Brock 1997 Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials Cancer Treat Rev 23 1 35 61 9189180 10.1016/S0305-7372(97)90019- 0 1:CAS:528:DyaK2sXktFOrt7w%3D
27. U Akbar T Jones J Winestone, et al. 2009 Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection J Neurooncol 94 2 203 212 19337695 10.1007/s11060-009-9857-9 1:CAS:528:DC%2BD1MXps1CjtL8%3D